Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human papillomavirus type 16 (HPV16) oncoprotein E7 is a multifunctional viral protein that plays a central role in the HPV life cycle and in the development of HPV-associated cancers, particularly cervical cancer. It drives quiescent cells into the cell cycle by stimulating progression from G1 to S phase, facilitating viral genome replication. E7 binds to retinoblastoma tumor suppressor protein (pRB), as well as related pocket proteins p107 and p130, leading to their degradation. It also interacts with cullin 2 ubiquitin ligase complex contributing to pRB degradation and interacts with additional targets such as histone deacetylases and the large retinoblastoma-associated factor p600.
Not applicable, but target of therapeutics
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 16 Oncoprotein E7 (HPV16 E7).